CRYSTAL CARGILL: Open Payments
NPI 1407335854 · PONTIAC, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 94 payments from 14 companies in 2025. Trend: 2023 $1,515 · 2024 $1,553 · 2025 $1,765
Food & beverage: $1,663Education: $101
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $270 |
| Teva Pharmaceuticals USA, Inc. | 13 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $238 |
| Neurocrine BioSciences, Inc. | 11 | $210 |
| ABBVIE INC. | 12 | $185 |
| Lundbeck LLC | 8 | $157 |
| Alkermes, Inc. | 6 | $123 |
| Janssen Pharmaceuticals, Inc | 6 | $115 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Almatica Pharma LLC | 2 | $46 |
Products named: REXULTI, CAPLYTA, INGREZZA, VRAYLAR, UZEDY, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
